Globe Life's Valuation Analysis: Undervalued by 63.3% According to Excess Returns Model

Globe Life's share price has risen 28.7% over the last year and 51.2% over five years. The company scores a solid 6/6 valuation check, suggesting it is undervalued on every metric. The Excess Returns model estimates Globe Life is trading at a 63.3% discount to its intrinsic value, indicating it is undervalued. The market has focused on Globe Life's position as a steady player in the life and health insurance space, but the company's resilient cash flows and disciplined capital allocation are also key factors in its value.